Vyndaqel (Tafamidis)
Vyndaqel (Tafamidis)
Vyndaqel (Tafamidis) is a prescription medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and progressive disease affecting the heart. Vyndaqel works by stabilizing the transthyretin protein, preventing the formation of amyloid deposits that can cause damage to the heart and other organs. It is crucial for improving the quality of life and extending survival for patients with ATTR-CM.
Why Choose Vyndaqel (Tafamidis)?
- Disease Management: Helps manage and treat transthyretin amyloid cardiomyopathy.
- Heart Health: Stabilizes transthyretin protein, reducing harmful amyloid deposits.
- Improved Quality of Life: Enhances functional capacity and overall well-being.
- Extended Survival: Contributes to increased lifespan in patients with ATTR-CM.
- Convenient Dosing: Available in easy-to-take oral capsules.
How to Use Vyndaqel (Tafamidis)?
- Consult Your Doctor: Always use Vyndaqel under the supervision of a healthcare professional.
- Follow Prescription Instructions: Take the medication exactly as prescribed.
- Regular Monitoring: Schedule routine check-ups to monitor heart function and overall health.
- Adhere to Dosage Schedule: Take the medication at the same time each day for optimal results.
- Report Side Effects: Inform your doctor of any adverse reactions or concerns immediately.
Important Safety Information about Vyndaqel
- Allergies: Inform your doctor if you have any known allergies to Tafamidis or other ingredients.
- Medical History: Discuss your medical history, especially liver conditions or other chronic illnesses.
- Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
- Interactions: Provide a list of all medications, supplements, and herbal products you are taking to avoid potential interactions.
- Storage: Store Vyndaqel at room temperature, away from moisture and heat.
Fact Table
Facts | Details |
Brand Name | Vyndaqel |
Generic Name | Tafamidis |
Drug Class | Transthyretin Stabilizer |
Indication | Treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) |
Mechanism of Action | Stabilizes transthyretin protein, preventing amyloid deposit formation |
Dosage Form | Oral capsules |
Strengths Available | 20 mg |
Recommended Dosage | One capsule (20 mg) taken once daily |
Route of Administration | Oral |
Approval Date | Approved by the FDA on May 3, 2019 |
Key Benefits | Disease management, improved quality of life, extended survival, convenient dosing |
Common Side Effects | Fatigue, diarrhea, urinary tract infections, muscle spasms |
Storage Conditions | Store at room temperature (20°C to 25°C), away from moisture and heat |
Contraindications | Hypersensitivity to Tafamidis or any component of the formulation |
Pregnancy Category | Consult a healthcare provider; potential risks versus benefits should be considered |
Lactation | Not recommended; consult a healthcare provider |
Monitoring | Regular cardiac function tests and liver function tests recommended |
Interactions | Possible interactions with other medications; provide a list of all current medications to the doctor |
Common Side Effects
Like all medications, Vyndaqel (Tafamidis) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
- Fatigue
- Diarrhea
- Urinary Tract Infections
- Muscle Spasms
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
How Can You Buy Vyndaqel (Tafamidis)?
You can order Vyndaqel (Tafamidis) using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.